Skip to main content
Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · IEX Real-Time Price · USD
6.02
-0.13 (-2.11%)
May 20, 2024, 9:30 AM EDT - Market open

Telomir Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Current2023
Market Capitalization
178-
Enterprise Value
1800
PB Ratio
60.66-
EV/EBITDA Ratio
--0.01
EV/EBIT Ratio
--0.01
EV/FCF Ratio
--0.03
Debt / Equity Ratio
-0.03
Debt / EBITDA Ratio
--0.01
Debt / FCF Ratio
--0.03
Quick Ratio
7.000.10
Current Ratio
7.200.33
Interest Coverage
--6.96
Return on Equity (ROE)
--1045.40%
Return on Assets (ROA)
--542.10%
Return on Capital (ROIC)
--111.38%
Earnings Yield
-10.30%-
Buyback Yield / Dilution
-3.50%-8.16%
Total Shareholder Return
-3.50%-8.16%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).